GDRX GoodRx
- 4.550
- +0.270+6.31%
- 4.600
- +0.050+1.10%
GoodRx News
GoodRx | 4: Statement of changes in beneficial ownership of securities-Officer Voermann Karsten
GoodRx | 3: Initial statement of beneficial ownership of securities-Officer Barnes Wendy Lynn
GoodRx | 4: Statement of changes in beneficial ownership of securities-Director Hirsch Douglas Joseph
GoodRx | 4: Statement of changes in beneficial ownership of securities-Director Bruehlman Ronald E
GoodRx | 4: Statement of changes in beneficial ownership of securities-Director Kennedy Kelly J.
GoodRx | SCHEDULE 13D/A: Others
GoodRx | SCHEDULE 13D/A: Others
GoodRx | 8-K: Current report
GoodRx | 4: Statement of changes in beneficial ownership of securities-Officer Wagner Scott
GoodRx | 4: Statement of changes in beneficial ownership of securities-Officer Voermann Karsten
GoodRx | 4: Statement of changes in beneficial ownership of securities-Officer Nabiey Romin
GoodRx | 144: Notice of proposed sale of securities pursuant to Rule 144
GoodRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ameriprise Financial, Inc.(5.15%),Columbia Management Investment Advisers, LLC(5.15%)
GoodRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rubric Capital Management LP(4.75%),David Rosen(4.75%)
GoodRx | 3: Initial statement of beneficial ownership of securities-Director Bruehlman Ronald E
GoodRx | 4: Statement of changes in beneficial ownership of securities-Director Bruehlman Ronald E
GoodRx | 4: Statement of changes in beneficial ownership of securities-Officer Wagner Scott
GoodRx | 4: Statement of changes in beneficial ownership of securities-Officer Nabiey Romin
GoodRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.02%)
GoodRx | 10-Q: Q3 2024 Earnings Report
No Data